{
    "2018-12-21": [
        [
            {
                "time": "2018-07-15",
                "original_text": "Pfizer Xtandi Succeeds in Late-Stage Prostate Cancer Study",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Xtandi",
                        "Late-Stage",
                        "Prostate Cancer",
                        "Succeeds"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-11-20",
                "original_text": "Interesting LLY Put And Call Options For March 2019",
                "features": {
                    "keywords": [
                        "LLY",
                        "Options",
                        "March 2019"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-30",
                "original_text": "Pharma Stock Roundup: GSK, PFE Ink Consumer Health JV, JNJ Hit by Talc Allegations",
                "features": {
                    "keywords": [
                        "GSK",
                        "PFE",
                        "Consumer Health",
                        "JV",
                        "JNJ",
                        "Talc Allegations"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-11-05",
                "original_text": "Lilly's Shares Rise on Robust 2019 View, Dividend Hike",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Shares Rise",
                        "Robust 2019 View",
                        "Dividend Hike"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}